SecBot SecBot
SECBOTREPLAY Home › Report › AZN

AZN · AstraZeneca filed a Form 6-K reporting the vesting of a long-term…

ASTRAZENECA PLC · 6-K filed Aug 19, 2026 at 09:43 ET

At the news

NEUTRALIMPACT 2/10

6-K filed Aug 19, 2026 at 09:43 ET

AstraZeneca filed a Form 6-K reporting the vesting of a long-term performance share award to CFO Aradhana Sarin. The award, granted in 2021 under the AstraZeneca Performance Share Plan, vested on 17 August 2026 after a three-year performance period and a two-year holding period. This is a routine administrative disclosure regarding executive compensation and has no material impact on the company's financials or operations.

  • CFO Aradhana Sarin received 11,133 ordinary shares upon vesting of a 2021 performance share award.
  • The shares were acquired for nil consideration under the AstraZeneca Performance Share Plan.
  • The fair market value at vest was £114.60 per share.
  • Shares were withheld to satisfy tax obligations; the net change in beneficial interest is not disclosed.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access